Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Mazdutide

A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects

Innovent · Phase 1 · Completed · Enrollment 48

NCT05815680

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
warfarin+atorvastatin+IBI362n/rn/rn/rn/r
metformin+digoxin+IBI362n/rn/rn/rn/r

Not shown

  • warfarin+atorvastatin+IBI362: endpoint not reported
  • metformin+digoxin+IBI362: endpoint not reported